STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZBIO
  4. [ARS] Zenas BioPharma, Inc. SEC Filing

[ARS] Zenas BioPharma, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - Zenas BioPharma, Inc.

ARS Filing - Zenas BioPharma, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Zenas BioPharma, Inc. (ZBIO)

Acceptance Date: 2026-03-16T08:27:21.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Zenas BioPharma Inc.

NASDAQ:ZBIO

View ZBIO Stock Overview →

ZBIO Rankings

#2563 Ranked by Market Cap
N/A Ranked by Dividends

ZBIO Latest News

Mar 16, 2026
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 16, 2026
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 20, 2026
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 9, 2026
Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
Feb 4, 2026
Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

ZBIO Latest SEC Filings

Mar 16, 2026
[DEF 14A] Zenas BioPharma, Inc. Definitive Proxy Statement
Mar 16, 2026
[10-K] Zenas BioPharma, Inc. Files Annual Report
Mar 16, 2026
[8-K] Zenas BioPharma, Inc. Reports Material Event
Feb 13, 2026
[Form 4] Zenas BioPharma, Inc. Insider Trading Activity
Feb 13, 2026
[Form 4] Zenas BioPharma, Inc. Insider Trading Activity

ZBIO Stock Data

1.29B
39.38M
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM